Create your Personal Health Record and unlock support built around you
- Treatments and trials you qualify for
- Education for your stage of care
- Financial support for your medications
- Solutions to your side effects
Is Autologous Stem Cell Transplant Still Standard of Care in Myeloma? New Data from EHA 2026
HealthTreeDescription
At EHA 2026, researchers presented new data examining the role of ASCT in the modern treatment era. In this video, we review the latest evidence comparing transplant-based approaches with newer treatment strategies and discuss whether ASCT continues to provide meaningful benefits in progression-free survival, overall survival, and depth of response.
If this video has helped you or a loved one, consider donating to HealthTree. Every donation helps us continue to create free and high-quality blood cancer educational content: https://give.healthtree.org/give/628617/src=htu
For an organized lesson structure, watch on our site here: https://linktr.ee/HealthTreeUniversity
Create a free account to track your progress, bookmark lessons, and keep up-to-date on the latest advancements in treating cancer!
Patients have the key to find cures for cancer. Learn more about HealthTree's services here: https://healthtree.org/curehub?utm_source=social+media&utm_medium=htu+youtube&utm_campaign=htu-curehub&utm_content=general
Educated and empowered patients have better outcomes. We've partnered with hundreds of medical experts and doctors to help you learn more about your disease.